
Cogstate
Cogstate Ltd is a neuroscience company focused on optimizing brain health assessments. They provide digital cognitive assessment tools and services for clinical trials, healthcare, and research, aiming to improve the detection and measurement of cognitive function. Their solutions support the development of new medicines and enable earlier clinical insights in healthcare.
Short position
Cogstate (ASX:CGS) has 0.03% of its shares on issue reported as short positions as of 5 Oct 2026, or about 46,761 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.81% in July 2023. CGS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Cogstate (CGS) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in USD, the reporting currency
- Revenue
- 60.9MM (source: ASX (Markit))vs 53.1MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- 11.9MM (source: ASX (Markit))vs 10.1MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- EPS (basic)
- n/avs n/a (FY25)
- Rev YoY
- +14.6%FY
- EPS YoY
- n/aFY
- ASX (Markit)
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- 19.5%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a (reports in USD)
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (USD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 29 Sep 2026.
Financial statements
Figures in USD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | 60.9MM (source: ASX (Markit)) | 53.1MM (source: ASX (Markit)) | 43.4MM (source: ASX (Markit)) | 40.5MM (source: ASX (Markit)) |
| NPAT | 11.9MM (source: ASX (Markit)) | 10.1MM (source: ASX (Markit)) | 5.4MM (source: ASX (Markit)) | 3.6MM (source: ASX (Markit)) |
| Shares | 169.9M | 168.9M | 170.8M | 173.2M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- FY26 Financial Results and Operational UpdateFinancial Report18 Aug 2026via asx_announcements
- FY26 Appendix 4EAnnual Results18 Aug 2026via asx_announcements
- FY26 Annual ReportAnnual Report18 Aug 2026via asx_announcements
- FY26 Full Year Results and Investor Webcast NotificationFull Year Results10 Aug 2026via asx_announcements
- App 4D and Financial Statements Half-Year Ended 31 Dec 2025Half Year Results19 Feb 2026via asx_announcements
- Cogstate 1H26 Financial ResultsFinancial Report19 Feb 2026via asx_announcements
- FY26 Half Year Results and Investor Webcast NotificationHalf Year Results13 Jan 2026via asx_announcements
- View PosterFinancial Report31 Dec 2025via crawler
- View PosterFinancial Report31 Dec 2025via crawler
- View PosterFinancial Report31 Dec 2025via crawler
Showing 10 of 29 reports